Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2000, p. 453-455, Vol. 44, No. 2
Laboratoire de Bactériologie,
Hôpital Universitaire du Bocage, B.P. 1542, 21034 Dijon
Cedex,1 and Centre National de la
Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper,2 France
Received 10 May 1999/Returned for modification 18 August
1999/Accepted 5 November 1999
TEM-56 produced by a Klebsiella pneumoniae clinical
isolate is a novel
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of TEM-56, a Novel
-Lactamase
Produced by a Klebsiella pneumoniae Clinical
Isolate
-lactamase of isoelectric point 6.4 that confers
a moderate resistance level to expanded-spectrum cephalosporins. The
amino acid sequence deduced from the corresponding bla gene showed two amino acid replacements with respect to the TEM-2 sequence: Glu-104 to Lys and His-153 to Arg. This enzyme showed catalytic properties close to those of TEM-18. Thus, TEM-56 appears as a new TEM
mutant, an intermediary between TEM-18 and the extended-spectrum
-lactamase TEM-21.
*
Corresponding author. Mailing address: Centre National
de la Recherche Scientifique, UMR175, 6 rue de
l'Université, 29000 Quimper, France. Phone: 33-2 98 90 80 35. Fax: 33-2 98 90 80 31. E-mail:
roger.labia{at}univ-brest.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»